Serenoa repens extract additionally to quinolones in the treatment of chronic bacterial prostatitis. The preliminary results of a long term observational study

  • Konstantinos Stamatiou | stamatiouk@gmail.com Urology Department, Tzaneio Hospital, Pireas, Greece.
  • Nikolaos Pierris Urology Department, Tzaneio Hospital, Pireas, Greece.

Abstract

Introduction: Chronic prostatitis displays a variety of symptoms (mainly local pain exhibiting variability in origin and intensity). The purpose of this article is to briefly present the preliminary results of our study examining the role of phytotherapeutic agents in the treatment of chronic prostatitis patients. Materials and methods: The study included in total fifty-six consecutive patients who visited the outpatient department. Subjects were randomized into two groups. Subjects in the first group (28 patients) received prulifloxacin 600 mg for 15 days, while subjects in the second group (28 patients) received prulifloxacin 600 mg for 15 days and Serenoa repens extract for 8 weeks. The response was tested using laboratory and clinical criteria. Results: We found statistically significant differences between the two groups regarding pain regression and no statistically significant regarding bacterial eradication. Moreover however while sexual dysfunction improvement was equally achieved in both groups, improvement of urinary symptoms was more evident in the 2nd group especially after the completion of the antibiotic treatment. Conclusions: Serenoa repens extract for 8 weeks seems to improve prostatitis related pain. Further randomized, placebo-controlled studies are needed to substantiate safer conclusions.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.
Published
2013-12-31
Info
Issue
Section
Original Papers - Prostate
Keywords:
Chronic prostatitis, Phytotherapeutics, Quinolones, Pain, Serenoa repens
Statistics
  • Abstract views: 1768

  • PDF: 1622
How to Cite
Stamatiou, K., & Pierris, N. (2013). Serenoa repens extract additionally to quinolones in the treatment of chronic bacterial prostatitis. The preliminary results of a long term observational study. Archivio Italiano Di Urologia E Andrologia, 85(4), 190-196. https://doi.org/10.4081/aiua.2013.4.190